Power Law company profile

Translate Bio

Biotech & Life Sciences · Cambridge, United States · Founded 2011 · IPO 2018 Unicorn

Developing mRNA medicines to restore protein function

Valuation

$3.20B

Market cap · 2026

Revenue

$139M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

10 investors on Translate Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Partners Innovation Fund

M Ventures

Atlas Venture

SR One

Omega Funds

Series B+ 5 investors entered at this stage

Brookside Capital

Pfizer

Transformation Capital

Monsanto Growth Ventures

Rock Springs Capital

Global footprint

Where Translate Bio has talent and traffic

Workforce by country

🇺🇸 United States · Cambridge HQ

Book a demo for the full country breakdown

Patent intelligence

$371M patent portfolio · 170 active families

Estimated portfolio value

$371M

11.6% of market cap · 5.5× smaller than top peer Ablynx ($2B)

170 active patent families

Where Translate Bio innovates Molecular biologyCell biologyBiochemistryProteinOligonucleotide

Where Translate Bio concentrates vs peers

Each axis is a top-10 topic across Translate Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Translate Bio

An AI-synthesized read of the highest-engagement posts about Translate Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Translate Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles